🔗 Share this article

An underground economy for unlicensed slimming drugs is propelled by TikTok fitness influencers and vendors on communication apps, based on new investigations.

Experimental Treatment Acquiring Popularity Online

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Viewers are encouraged to contact these profiles privately for source information, while also obtaining promotional offers.

Active Trade on Social Networks

Separately, a robust trade exists on Telegram, where groups with thousands of members share “before and after” images, injection guides and claims of rapid British shipping. Vendors promote the drug there before redirecting customers to other platforms for transactions.

Understanding The Experimental Drug

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Healthcare Experts Voice Concerns

However, doctors and pharmacists have cautions that the sale of what is still an unapproved medication in the UK is worrisome and could lead to users administering substances of unknown origin.

Several professionals stated the demand for the experimental drug could be linked to the rising price of licensed weight loss treatments such as Mounjaro.

Legal Position and Enforcement

Selling retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be promoted or supplied for personal consumption under the British medical regulations.

Some influencers attempt to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still breach pharmaceutical, marketing, and consumer regulations, potentially leading to fines, prosecution or prison.

Platform Reaction and Material Removal

Based on TikTok, the service has taken down violative material and prohibited associated keywords and search suggestions. The organization said it was dedicated to maintaining the service safe and allocating resources in strengthening enforcement strategies.

Digital Marketplace Activities

Investigations also found groups with up to nine thousand participants selling retatrutide using the platform's built-in search feature, which operates like a online catalog. Typing “retatrutide” instantly displays groups with thousands of users, filled with photos of weight loss, glowing testimonials and step-by-step instructions for mixing or administering at home.

After moments of entering one community, a seller posted WhatsApp details, where most purchases occur. The seller sent an guidebook and promised shipping within 48 hours. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None asked about body mass, health issues or past usage.

Item Details and Pricing

Inside these communities, posts show black plastic parcels with Royal Mail labels, stating to contain new batches. One message read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at home with purified liquid, or ready-to-use injectors typically priced at £160 for 20mg. When asked how long a pen should last, sellers give contradictory answers ranging from a several days to “depends on your body”.

Service Oversight and Safety Measures

A representative for the messaging service stated it regularly monitored dangerous material on its service including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering materials they can’t verify. Even if the research behind this drug is valid, these online versions may not contain what they advertise,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.

A medical professional of an online medical service connected the increase in interest to recent price rises for authorized slimming drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit treatments are extremely risky. You cannot know what’s contained or whether the environment they were made in was clean,” she said.

Her team has already seen individuals harmed by personal administration from unconfirmed suppliers. “We understand the frustration, but purchasing from Telegram or communication platforms is taking chances with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”

Producer Statement

A representative from Eli Lilly stated retatrutide was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for human use,” they explained, adding that any product “falsely representing itself as a Lilly experimental product not yet approved … may subject patients to possibly significant health risks”.